We conclude that this clinical problem can be reproduced in mouse models; describe techniques that could enhance our understanding of peritoneal tumour spread and be useful in the development of novel treatments; and show how shRNA to the chemokine receptor CXCR4 had a significant effect on the development of intraperitoneal tumour deposits. The gene discussed is CXCR4; the disease is neoplasm.